Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
58 Leser
Artikel bewerten:
(0)

IneedMD Inc. Discusses EKG Glove Expansion into China with Tianjin Officials

NEW YORK, May 16, 2014 /PRNewswire/ --Robert Riola, CTO of IneedMD Inc., has entered into discussions with Shuming Zhong, the Deputy Head of Tianjin's Wuqing District, in regard to Chinese FDA approval for the manufacturing of the EKG Glove. IneedMD Inc. expects to expand in Tianjin for this powerful and exciting new technology. The two met in person last week at the Harvard Club to discuss this endeavor.

Robert Riola, CTO of IneedMD Inc (left) and Zhong Shu Ming, Vice Magistrate of Wuqing District, Tianjin China (right) at the Harvard Club in New York City last week.

The EKG Glove has already received both FDA approval and the EU's CE Marking, and IneedMD Inc. is now reaching out towards China for its manufacturing, and distribution capabilities. Initially developed by Dr. Govindan Gopinathan MD, the co-founder of IneedMD Inc., the EKG Glove is an advanced new technology that is recognized on a global level. In particular, "China has a particular need for the product due to their massive population and explosive economic situation" explains Mr. Riola.

Tianjin, known as the Silicon Valley of Asia, has been supportive of advanced technologies and the development of innovative solutions for some time. With a wealth of cutting-edge technology firms and a focus on manufacturing, Tianjin is the ideal location for the further development of IneedMD Inc.'s EKG Glove.

Mr. Zhong will lead both Mr. Riola, and Dr. Gopinathan on a Tianjin-sponsored tour of the facilities and the area to determine the best way to move forward in this mutual cooperation. They will be discussing the finalization of the EKG Glove's approval with the Chinese FDA to ensure that the Chinese people can benefit from this new and advanced medical technology.

"I have personally invited Dr. Gopinathan and Mr. Riola to be my guests for a Tianjin sponsored tour of the region," explained Mr. Zhong, "where we will invite CFDA officials to discuss the finalization of the EKG Glove approval so that China can benefit from this powerful new technology." Once cleared, IneedMD Inc. will be working with the officials in the Tianjin region to begin manufacturing of the EKG Glove and distribution within the Chinese marketplace.

About IneedMD, Inc.
The company, IneedMD Inc. has developed a proprietary, disposable device used in the diagnosis, prevention, and monitoring of cardiovascular disease called The EKG Glove'. The EKG Glove' is designed to obtain an ECG/EKG using pre-positioned electrodes affixed to the underside of a glove-like sheath. The EKG Glove is portable, disposable, and leverages printed circuit technology to deliver a full 12 lead diagnostic electrocardiogram (ECG) with a single use "peel and stick" action. The single use aspect of The EKG Glove' targets the growing problem of Hospital Acquired Infections (HAIs), while also reducing the 30%, nearly 1 in 3, error rate associated with the painstaking manual placement of leads. Along with its highly sanitary profile, the speed to care provided by the use of The EKG Glove' improves the care and monitoring of cardiovascular disease, and eclipses that of any traditional ECG system.

Through the use of our unique, patented, break-through technology, a more rapid and complete 12-lead ECG exam, analysis and diagnosis can be achieved by which time, money, and lives can be saved.

IneedMD Inc. is the only company to date that is in a unique position to deliver meaningful, significant benefits to both patients, and doctors by allowing virtually anyone to administer a full 12-Lead ECG exam anytime, anywhere, and in less than 60 seconds.

For more information about IneedMD Inc. and the revolutionary EKG Glove, visit any of our social media properties: Twitter Facebook YouTube SoundCloud RebelMouse Google+

Photo - http://photos.prnewswire.com/prnh/20140516/88413

SOURCE IneedMD Inc.

© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.